Carteolol hydrochloride,CAS:51781-21-6
MF:C16H25ClN2O3
Purpose:Used to reduce intraocular pressure, indications: treatment for primary open-angle glaucoma, angle closure glaucoma, secondary glaucoma, and high intraocular pressure.
Classification :
PRODUCT DETAILS
Specifications | |
Product Name | 5-[3-[(tert-butyl)amino]-2-hydroxypropoxy]-3,4-dihydro-2-quinolone monohydrochloride |
CAS No. | 51781-21-6 |
Test Standard | Enterprise standard |
| |
Items | Standard |
Appearance | White to almost white crystalline powder |
Identification | The retention time of the principal peak is similar to the reference spectrum |
Solubility | Easy to dissolve in water, slightly soluble in methanol, slightly soluble in 96% ethanol, almost insoluble in dichloromethane |
Melting Point | 276~278℃ |
PH | 5.0~6.0 |
Loss on drying | ≤0.5% |
Heavy Metals | ≤0.1% |
Related Substances | Unidentified single impurity≤0.20% |
Total impurities≤0.5% | |
Assay | 99.0%-101.0% |
Packaging | Inner packaging:two-layer LDPE bags, Outer packaging:cardboard drum, |
HOT PRODUCTS
(R)-(+)-3-Chloro-1-Phenyl-1-Propanol,CAS#100306-33-0
2-(2'-hydroxy-3'-methallyl-5'-methylphenyl)benzotriazole,CAS#98809-58-6
(S)-4-(3-chloro-4-MethoxybenzylaMino)-5-ethoxycarbonyl-2-(2-hydroxyMethyl-1-pyrrolidinyl)pyriMidine,CAS#330785-83-6
(S)-4-((3-chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)pyrrolidin-1-yl)pyrimidine-5-carboxylic acid,CAS#330785-84-7
Dapoxetine,CAS#119356-77-3
2',4'-Dihydroxyacetophenone,CAS#89-84-9
Bazedoxifene Acetate,CAS#198481-33-3
Vardenafil hydrochloride trihydrate,CAS NO.:330808-88-3
Avanafil, CAS:330784-47-9
Bevenopran,CAS:676500-67-7